1-4 of 4
Talia Zahra
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Polatuzumab- Rituximab with or without Bendamustine As Second-Line Therapy for Relapsed Refractory Large B-Cell Lymphomas: Single Center Experience

Ariel Perez Perez, Shreya Saxena, Tiba Al Sagheer, Muni Rubens, Talia Zahra, George Nahas, Alex V. Mejia Garcia, Lyle Feinstein, Lisa Reale, Marco Andres Ruiz, Peter L. Citron, Atulya Khosla, Manmeet Ahluwalia, Guenther Koehne, Yuliya P.L. Linhares
Journal: Blood
Blood (2022) 140 (Supplement 1): 6672–6673.
https://doi.org/10.1182/blood-2022-163461
Published: 2022
Journal Articles

Trial in Progress: Zanubrutinib with Pemetrexed for the Treatment of Relapsed/Refractory Primary and Secondary CNS Lymphomas: A Phase II Trial with a Safety Lead-in

Yuliya Linhares, Ariel Perez Perez, Tiba Al Sagheer, George Nahas, Alex Mejia-Garcia, Muni Rubens, Talia Zahra, Lyle Feinstein, Lisa Reale, Marco Andres Ruiz, Peter L. Citron, Yazmin Odia, Guenther Koehne
Journal: Blood
Blood (2022) 140 (Supplement 1): 12061–12063.
https://doi.org/10.1182/blood-2022-167064
Published: 2022
Journal Articles

Evaluating Acute Myeloid Leukemia Induction Regimens in Elderly Patients with Unfavorable Risk Cytogenetics That Are Candidates for Intensive Remission Therapy

Monica Tadros, PharmD, Guenther Koehne, MDPhD, Talia Zahra, MD, Jessica Unzaga, PharmD, Moe Shwin, Nicholas Chow
Journal: Blood
Blood (2020) 136 (Supplement 1): 17.
https://doi.org/10.1182/blood-2020-141276
Published: 2020
Journal Articles

Compliance with Expert Recommendations of Sickle Cell Pain Management—a Single Institution Review

Danny A. Landau, MD, Talia Zahra, MD, John Graham, MD, Michael Landis
Journal: Blood
Blood (2017) 130 (Supplement 1): 5590.
https://doi.org/10.1182/blood.V130.Suppl_1.5590.5590
Published: 2017